Skip to main content
. 2022 May 4;235(3):392–400. doi: 10.1097/XCS.0000000000000261

Table 1.

Demographics and Operative Characteristics

Characteristic Total
n = 233
Method of spinal analgesia p Value*
None
n = 85
ITM
n = 115
ITM+TAP
n = 33
Age, y, median (IQR) 67 (59, 73) 66 (57, 72) 67 (59, 73) 68 (59, 74) 0.7478
Sex, m, n (%) 120 (51.5) 41 (48.2) 62 (53.9) 17 (51.5) 0.7294
White, n (%) 211 (90.6) 80 (94.1) 98 (85.2) 33 (100) 0.0140
BMI, kg/m2, median (IQR) 27 (23, 31) 27 (24, 30) 27 (23, 32) 26 (26, 32) 0.5757
COPD, n (%) 12 (5.2) 3 (3.5) 6 (5.2) 3 (9.1) 0.5151
Anxiety, n (%) 31 (13.3) 9 (10.6) 19 (16.5) 3 (9.1) 0.3528
Depression, n (%) 64 (27.5) 26 (30.6) 30 (26.1) 8 (24.0) 0.7055
Substance use disorder, n (%) 11 (4.7) 4 (4.7) 5 (4.4) 2 (6.1) >0.999
Alcohol use disorder, n (%) 32 (13.7) 16 (18.8) 15 (13.0) 1 (3.0) 0.0782
Chronic opioid use, n (%) 58 (24.9) 24 (28.2) 27 (23.5) 7 (21.2) 0.6472
Malignant pathology, n (%) 193 (84.3) 68 (81.9) 95 (83.3) 30 (93.8) 0.2739
Operative duration, min, median (IQR) 378 (286, 475) 349 (269, 446) 397 (292, 495) 381 (349, 461) 0.0471
Open approach, n (%) 190 (81.6) 69 (81.2) 91 (79.1) 30 (90.9) 0.3048
Year of operation, n (%) <0.0001
 2014 34 (14.6) 34 (40.0) 0 0
 2015 18 (7.7) 18 (21.2) 0 0
 2016 44 (18.9) 20 (23.5) 22 (19.1) 2 (6.1)
 2017 38 (16.3) 4 (4.7) 24 (20.9) 10 (30.3)
 2018 32 (13.7) 3 (3.5) 20 (17.4) 9 (27.3)
 2019 39 (16.7) 2 (2.4) 28 (24.4) 9 (27.3)
 2020 28 (12.0) 4 (4.7) 21 (18.3) 3 (9.1)
*

Analgesia cohorts are compared using chi-square test for categorical characteristics or Wilcoxon rank sum test for continuous characteristics.

Statistically significant.

IQR, interquartile range; ITM, intrathecal morphine; TAP, transversus abdominus plane block.